Letters to the Editor

Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy

Department of Haematology, Imperial College London, Hammersmith Hospital, London, UK.
Department of Haematology, Imperial College London, Hammersmith Hospital, London, UK.
Department of Haematology, Imperial College London, Hammersmith Hospital, London, UK.
Department of Haematology, Imperial College London, Hammersmith Hospital, London, UK.
Department of Haematology, Imperial College London, Hammersmith Hospital, London, UK.
Department of Haematology, Imperial College London, Hammersmith Hospital, London, UK.
Vol. 97 No. 9 (2012): September, 2012 https://doi.org/10.3324/haematol.2012.064618